Systematic reviews have also indicated that elevated CSF YKL-40/Aβ42 ratios and plasma YKL-40 levels are associated with brain atrophy, cognitive decline, and dementia risk, though results remain heterogeneous (Heneka et al., 2025). This evidence concerns the gene CHI3L1 and Brain atrophy.